These key words are from Dr. Levin in the CA-2 lecture class.


 
1. Sinus Tach : electrophysiology

2. SvO2, CO, Fick equation relationship
3. Factors affecting LV filling
4. Perioperative digoxin toxicity : management
5. Coronary art : def dominance
6. Compl brach art cannulation
7. Factors affecting defib' success
8. Cardiac output curves
9. Pacemacker nomenclature
10. CPB : noncoronay collateral flow
11. Causes of CPB hypotension
12. Amiodarone : side effects
13. ET CO2 during CPR
14. Causes of EMD
15. CBP for CABG : neurologic outcome
16. AVR surgery : Rx of hypertension
17. Myocardial ischemia : Dx



   
1. Sinus Tachycardia : electrophysiology back to top


Sinus tachycardia : when HR > 100 bpm. The rhythm is regular. The P:QRS ratio is 1:1, P, QRS, ST and T are normal (or non-specific ST-T changes)
Etiology : hypoxia, hypercarbia, pain (light anesthesia), hypovolemia, fever, sepsis, increased metabolism
Treatment : correct underlying problems first, then medications e.g. beta-blocker, ca-blocker, cholinergic drugs, etc.

Ref
1. Thomas SJ, Kramer JL. Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993.
2. Thys DM, Narang J. Electrocardiographic monitoring in Estafanous FG, Brash PG, Reves JG : Cardiac Anesthesia ; Principles and Clinical Practice 2nd ed. Lippincott William & Wilkins 2001





   
2. SvO2, CO, Fick equation relationship back to top

SvO2 or Mixed Venous Oxygen saturation is the oxygen saturation of the venous blood, should be sampled at the last place where the venous blood is all mixed and the standard sampling place is the blood drawn from the PA catheter (right before enter the lung for gas exchanges). Some PA catheter has the fiberoptic channel for continuous SvO2 monitoring. The same fiberoptic device placed in the internal jubular bulb will read the jugular venous bulb oxygen saturation.

SvO2 varied with CO, Hb, total body oxygen consumption and SpO2 as the formula :

As the formula imply, the SvO2 will change as

-Decrease SvO2 : increased O2 consumption e.g. fever, shivering, exercise, MH, thyroid storm
: decrease O2 delivery e.g. hypoxia, CO, anemia, abnormal Hb

-Increase SvO2 e.g. Lt. to Rt. shunt, high CO, impair tissue uptake (e.g. CN- toxicity), decrease O2 consumption e.g. hypothermia, Sepsis, Sampling error (e.g. wedged PA cath)

CO (Cardiac Output) is a product of stroke volume and heart rate (normal is 4-6.5 L/min). CO can be measured clinically by many methods. The most common is using PA catheter and thermodilution technique. The special PA catheter which allows nearly continuous (every 30 second) CO monitoring is available. Another method which will be discussed is Fick method. The commercial available Fick method device for CO monitoring, using CO2 is NICO which is already discussed in the forum update.


Fick Equation relationship

Adolph Fick, the German physiologist described the O2 as an indicator dilution for calculation of CO in 1870. The formula is
To measure CO by Fick method need the O2 consumption measurement which is done by collecting patient's exhaled air, respiratory gas analysis and indirect calorimetry. Some clinicians may use a constant basal value for O2 consumption (approx 200-250 mL/min).

Ref
Miller RD : Anesthesia 5th Ed. Churchill Livingstone 2000.




   
3. Factors affecting LV filling back to top

LV filling occurs in diastole which can be divided into 4 phases
1.) isovolumic relaxation
2.) rapid ventricular filling
3.) Diastasis or slow filling
4.) atrial systole
Many factors will affect LV filling, to start the thinking process from phase 1 the isovolemic relaxation which occurs after the aortic valve closes about 50-60 msec. The LV relaxation will create the pressure relatively negative, once the pressure in LV chamber below the LA, the mitral valve will open and allow the 2nd phase. The factor that will afftect this phase includes the LV compliance (decrease compliance or increase LV stiffness will reduce LV relaxation). Increase chamber stiffness may come from the myocardial tissue e.g. concentric hypertrophy or increase muscle stiffness that found in restrictive cardiomypopathies e.g. amyloidosis, hemochromatosis.

Mitral valve function is a major contribution to the 2nd phase, mitral stenosis or impair mitral valve function will impedes the rapid ventricular filling process.

Atrial systole or atrial kick contributes to LV filling about 20-30%. The loss of atrial contraction e.g. atrial fibrillation or atrial flutter will result in loss of atrial systole.

Overall, the heart rate also afffect the LV filling. The faster the heart rate, the shorter diastolic time and less LV filling.

Ref
Miller RD : Anesthesia 5th Ed. Churchill Livingstone 2000.





   
4. Perioperative digoxin toxicity : management back to top

Digoxin toxicity in awake patients presents with N-V, diarrhea, yellow vision, arrhythmia, gynaecomastia, etc
With the anesthetized patients, only a wide variety of arrhythmias can be observed. The most common is PVCs (unifocal and multifocal, oftens with bigeminy or trigeminy), A-V junctional escape rhythms, nonparoxysmal junctional tachycardia, paroxysmal atrial tachycardia with A-V block, 2nd degree A-V block, VT and VF. Hypokalemia will enhance digoxin effects.

Recommended Treatment
includes
  T maintain normal to high K level, repleted to 4.5 mEq/L.
T Lidocaine may be useful for ventricular ectopy, phenytoin can reverse the high degree AV block (central mechanism)
T Concomitant given drugs that will elevate digoxin level e.g. quinidine, verapamil and B-blocker should be discontinued.
T Temporary pacemaker may be required for severe bradycardia or advanced heart block that is non-responsive to pharmacologic approaches.
T Mg should be administered 1-2 gm empirically unless patient who has hypermagnesimia or impaired renal function.
T Specific treatment to reduce the absorption e.g. gastric emptying and activated charcoal should be considered in acute toxicity. Generally, most of the patients have been taking digoxin chronically and the toxicity aggravated by the elctrolytes derangement. Digoxin-specific Fab antibody fragments are the definitive treatment for hemodynamic significant arrhythmias.
T Digoxin level may be measured to follow the trend. However, in the patient who recieves Digoxin-Fab Ab, the level may increase due to the increase in Fab-bound digoxin and indistinguishable from free digoxin. The clinical improvement in arrhythmias during the treatment can be observed. If the clinical improvement is not manifested, the serum free digoxin can be measured by rapid ultrafiltration assays

Ref
1. Lionel H. Opie. Drugs For the Heart 3rd ed. W.B. Saunders 1991
2 . Thomas SJ, Kramer JL. Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993.





   
5. Coronary art : def dominance back to top

50% of patients have right dominant coronary circulation while 25% have left dominant and 25% are clasfied as indeterminant (angiographically). The right dominant means that a large part of posterior wall of LV is supplied by the post. descending branch of Rt. coronary artery and the A-V node is usually supplied by the right coronary artery.

For the left dominant, the posterior LV wall is supplied by a posterior descending branch of the circumflex coronary artery and the A-V node is also usually supplied from the left coronary artery.

Ref
1. Dinardo JA. Anesthesia for Cardiac Surgery 2nd Ed. Appleton & Lange 1998
2. Miller RD : Anesthesia 5th Ed. Churchill Livingstone 2000.




   
6. Complication of brachial artery cannulation back to top

Brachial artery cannulation is not recommended *1 because of the potential for thrombosis and ischemia of the lower arm and hand. Alternative sites such as the radial, femoral, or axillary artery should be chosen.*

Special concerns for brachial artery cannulation are - lack of collateral blood supply (compare to radial-ulnar system), needs a longer catheter, biceps tendon injury is possible, elbow flexion will interfere with monitoring, upper extremity compartment syndrome following brachial a. cannulation has been reported. However, Bazaral et al, reported over 3000 brachial artery cannulation with safety. Another concern with brachial a. cannulation (and also axillary a. cannulation) is the tip of the catheter may be close to the innominate or lt. carotid a. branch in the aortic arch, the automatic flushing with accidental air injection may cause cerebral embolisms. (more common with axilllary a. cannulation)

Other complications in general for arterial cannulation includes hematoma, arterial injury, thromboembolism, infection, nerve injury, AV malformation, loss of limbs, etc.

Ref
1. *American Heart Association. Chapter 12 p 12-5-12-6 Adjuncts for artificial Circulation in Advanced Cardiac Life Support 1994-1997
2. Miller RD : Anesthesia 5th Ed. Churchill Livingstone 2000.



   
7. Factors affecting defib' success back to top
-The correct paddle size, the correct position, the correct energy used.
-Early defibrillation allows more success or the longer period of VF, the less success of defibrillation.
-Course (high voltage) VF is easier to defib than fine (low voltage) fibrillation.
-Epinephrine is generally accepted to give for next defibrillation. But defibrillation should not be delayed for epinephrine administration.
-Transthoracic impedance plays an important role for external defibrillation. The resistance decreases with the larger paddle and the use of saline-soaked gauze pads or gels/creams and also successive shocks. Transthoracic impedance is slightly (significantly) higher during inspiration.
-Serum K of 5 mEq/L decreases the defibrillation threshold.
-After CPB, aortic perfusion pressure and duration of reperfusion after aortic cross-clamp removal ( should have mean BP at least 50 mmHg for > 5 min ). The reason is the anaerobic metabolism that occured in the subendocardial region need a longer period of washout of anaerobic products.
-myocardial temperature should be > 30 °C. (spontaneous fibrillation occurs at 28 °C)
-Patients with valvular heart disease are more difficult to obtain success defibrillation compare to patients with normal valvular functions.
-Lidocaine has been shown to reduce the number and energy needed for DC shocks but prophylactic lidocaine is not necessary.
Ref
1. Dinardo JA. Anesthesia for Cardiac Surgery 2nd Ed. Appleton & Lange 1998
2. American Heart Association. Advanced Cardiac Life Support 1994-1997






   
8. Cardiac output curves back to top

The cardiac output (CO) curves that we use in general clinical setting is from thermodilution (TD) technique. TDCO measurement is the modification of indicator (dye) dilution method which flow is determined from

CO curve from dye dilution technique
Picture from Peter R. Lichtenthal. Quick guide to Cardiopulmonary Care. Baxter

In clinical settings, the dilution is the temperature of the known amount of injectate (usually 10 cc of 5%DW or NSS). The thermister will detect changes of temperature at the tip of the PA catheter and calculate the flow as CO (L/min).
you don't need to remember this, just to make you have the idea what needed to calculate the CO
Picture from Baxtor-Quick Guide to cardiopulmonary care
Picture from Peter R. Lichtenthal. Quick guide to Cardiopulmonary Care. Baxter

Important points

1. TDCO is a measure of pulmonary blood flow, which in the absence of shunting, is equal to forward right heart output
2. CO is inversely proportional to the area under the PA temp-time curve
3. The injectate volume can vary from 1 to 10 ml but for adults, uses of 3-5 ml results in more within-patient variation than a 10 ml volume. (volume 1,2 and 3 ml have been shown to produce reliable results in infants and small children)
4. Injectate temp from 0 c to room temperature can be used. The accuracy and variability in adults is similar with either room temperature or iced injectate. (SB and A.fib have been reported with iced injectate)
5. There are large cyclical variations during different phases of mechanical ventilation due to variations in pulmonary blood flow.

TDCO are inaccurate in the presence of :
-low CO. CO is overestimated because low flows allows the injectate to get warm and reduces the area under curve.

-Lt. to Rt. intracardiac shunts (ASD, VSD) , often impossible for computer analysis due to the recirculation which results in a prolonged, flat deflection and interruption of exponential down slope of the curve.

-TR ; regurgitation of the injectate results in delayed clearance of the indicator from the Rt. heart. The curve is broad and low in amplitude which results in inaccurate assessment of forward CO.

-Rapid infusion of volume via peripheral line can results in variations of up to 80% in TDCO. The rapid infusions should be terminated or held at a constant rate for at least 30 seconds before measurement.

Ref
Dinardo JA. Anesthesia for Cardiac Surgery 2nd Ed. Appleton & Lange 1998




   
9. Pacemaker Nomenclature back to top

Five letter system for permanent pacemaker, 3 letter is the former system and also used for the transport or intraop pacemaker.
First letter
Second letter
Third letter
Fourth letter
Fifth letter
Chamber paced
Chamber sensed
Response (of pacemaker)
Programmability
Anti-tachycardia function
A (atrium)
A
T (triggered)
P (programmable)
O (none)
V (ventricle)
V
I (inhibited)
M (multiprogrammable)
P (pacing)
D (dual/both)
D
D (both T and I)
C (communicating)
S (shock)
O (none)
O (none)
R (rate modulation)
D (both)

The common modes of pacemaker are :
VOO : this is a fix asynchronous mode, just pace the ventricle regardless of intrinsic R wave. This is the most common mode used in the OR to disregard the electrical interference from the ESU. Ventricular fibrillation has been reported. The magnet that used in the OR will turn some models of pacemaker into this mode.
VVI : this mode paces the ventricle and senses the intrinsic R waves. If the pacemaker senses an intrinsic R wave, it turns off or inhibited.
DDD : The pacemaker senses P waves and R waves, paces the atrium and ventricle and has both inhibited and triggered activity - tatally automatic.


Ref
1. Thomas SJ, Kramer JL. Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993.
2. Estafanous FG, Brash PG, Reves JG : Cardiac Anesthesia ; Principles and Clinical Practice 2nd ed. Lippincott William & Wilkins 2001






   
10. CPB : noncoronay collateral flow back to top


After the institution of CPB, all venous return should be diverted to the CPB through the venous cannula (or cannulae) but there is still some blood returns that not going to the CPB machine. The blood return to the Rt. heart is mostly from coronay blood flow. The blood that returns to the left heart includes Thebesian vein, Bronchial veins, extracardiac Lt. to Rt. shunts e.g. BT shunt, imcompetent Ao valve

Ref
Dinardo JA. Anesthesia for Cardiac Surgery 2nd Ed. Appleton & Lange 1998





   
11. Causes of CPB hypotension back to top

The major causes of hypotension at initiation of bypass is the hemodilution which cause a great reduction in SVR and the loss of pulsatile flow. During CPB, the most serious possible cause of hypotension is the aortic dissection. Others includes
-measurement errors e.g. transducer problem, kinked artrial catheter
-reduced pump flow from
a. Inadequate venous return e.g. obstruction, air lock, venous cannulae kink, etc, Insuficient pump volume, Hypovolemia, Operating table is too low
b. Incomplete occlusion of pump heads
c. High aortic line pressure (reflecting distal obstruction e.g. kinking, etc)
-Vasodilation from e.g. volatile anesthetics, temperature, hemodilution


Ref
Thomas SJ, Kramer JL. Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993.




   
12. Amiodarone : side effects back to top

-Pulmonary ; this is the most serious side effect and may be dose related. Amiodarone can cause pneumonitis which further develop to pulmonary fibrosis (1-10%).
-Cardiac ; inhibition of SA or AV node
-CNS ; proximal muscle weakness, peripheral neuropathy, others e.g. headache, ataxia, tremors, impaired memory, insomnia, dreams, etc. (variable incidence)
-Thyroid : at a low dose (200-400 mg) 3-5 % of patients may develop hypothyroidism or hyperthyroidism. 10% may have silent alterations in thyroid function.
-GI ; nausea 50% (even with dose 200 mg daily), increased liver enzymes in 10-20%. These side effects usually resolve with dose reduction.
-Others ; corneal microdeposits (nearly all adult patients with prolonged treatment) which may cause impairment of visual acuity, Macular degeneration (rarely), 10 % of patients develop photosensitive slate-gray or bluish skin discoloration (after prolonged treatment .. 18 months).

Ref
1. Lionel H. Opie. Drugs For the Heart 3rd ed. W.B. Saunders 1991 p. 202-203
2 . Thomas SJ, Kramer JL. Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993.




   
13. ET CO2 during CPR back to top

Capnometry shows promise as a noninvsive measure of CO generated during ongoing CPR. Blood flow to the lungs depends on CO. In most patients in cardiac arrest, the CO2 that reaches the lungs diffuses out. Capnometry measures CO2 excretion through the endotracheal tube. In experimental models, end-tidal CO2 concentration during ongoing CPR correlated with CO, perfusion pressures, and successful resuscitation from cardiac arrest. Clinical studies have demonstrated that patients who were succesfully resuscitated from cardiac arrest had significantly higher end-tidal CO2 levels than patients who could not be resusciated. Capnometry can also be used as an early indicator of return of spontaneous circulation. Despite these promising studies, a number of factors must be considered. Large changes in the MV will affect the end-tidal CO2 reading. Thus, ventilation must be held relatively constant during the resuscitation effort. The administration of bicarbonate will increase CO2 excretion for several minutes before it returns to baseline measurements. High doses of pressor agents such as epinephrine will increase myocardial perfusion pressure but decrease CO. CO2 excretion will decrease with decreased blood flow to the lungs. Finally, for capnometry to be a truly useful prognostic indicator of successful resuscitation, clinical studies must be demonstrate that strategies that improve end-tidal CO2 levels will result in improved outcome from cardiac arrest. In summary, end tidal CO2 monitoring during cardiac arrest can be useful as a noninvasive indicator of cardiac output generated during CPR. Further research needs to be done to determine its use as a prognostic inidicator in clinical practice.

Ref
American Heart Association. Chapter 12 p 12-5-12-6 Adjuncts for artificial Circulation in Advanced Cardiac Life Support 1994-1997



   
14. Causes of EMD back to top

EMD or Electromechanical Dissociation is a term that is recently called by the ACLS as a PEA (Pulseless Electrical Activity). EMD is a state which organized elctrical depolarization occurs throughout the myocardium but no synchronous shortening of the myocardial fiber occurs. Mechanical contraction are absent. The term pseudo-EMD is called when there is an electrical activity associated with mechanical contractions, only these contractions do not produce a blood pressue detectable by the usual methods of palpation or sphygmomanometer. The most common causes of PEA is hypovolemia, the other possible causes are cardiac tamponade, tension pneumothorax, massive PE, massive MI, Hypothermia, hypoxia, durg overdoses [ tricyclics, digoxin, b-blockers, Ca channel blockers], Hyperkalemia, preexisting acidosis, etc. The Algorithm for PEA is as shown below.

Ref
American Heart Association. Chapter 1p 1-21-1-25 Essentials of ACLS in Advanced Cardiac Life Support 1994-1997


 


   
15. CBP for CABG : neurologic outcome back to top

The cerebral injury has been recognized as a complication asssociated with open heart surgery with CPB. The incidence of various types of neurologic injuries in CABG compare to peripheral vascular surgery is shown in this table.


New Neurologic Findings
CABG (n=308)
Peripheral Vascular Surgery(n=49)
Fatal cerebral injury
1 (0.3%)
0
Depressed consciousness > 24 hrs
10 (3%)
0
Stroke
15 (5%)
0
Reversible ischemic deficit
9 (3%)
0
Ophthalmological abnormalities
78 (25%)
0
Primitive reflexes
123 (39%)
2 (4%)
Psychosis
4 (1%)
0
Peripheral neuropathy
37 (12%)
7 (14%)
Data from : Shaw P, Bates D, Cartlidege NEF, et al: Early neurological complications of coronary artery bypass surgery. BMJ 1985; 291:1384-1376; and Shaw PJ, Bates D, Cartlidge NEF, et al : neurologic and neurophyschological morbidity following major surgery : Comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987; 18:700-707)

The risk factors of neurologic injury.
-Age > 75 yr or < 1 mo
-Previous neurologic injury or stroke
-Ascending Aortic Atherosclerosis
-Genetic predisposition : APOEepsilon 4 allele
-DM
-Hypertension
-Peripheral vascular disease
-Three-vessel coronary artery disease
-poor preop LV function or LV thrombi
-prolonged CPB associated with poor neurologic outcome, membrane oxygenator produce fewer numbers of microscopic gas emboli
-DHCA

Controversies in perioperative management
1. Glucose management : the evidence of studies in the dogs shows the hyperglycemic CPB results in poor neurologic outcome but the clinical studies cannot confirm this.

2.
Mild and moderate hypothermia : Hypothermia has long been considered to provide a "cerebral protection" during CPB. However the concepts of normothermic cardioplegia (warm) started iin the early 1990s has been great interest and many studies still show controversies. The conclusion : current evidence suggest that sustained normothermia during CPB is associated with less favorable outcomes.

3. Acid-Base management
: it has been unclear which hypothermia acid-base strategy (pH stat vs alpha-stat) might be most appropriate for humans during hypothermic CPB because humans are neither poikilotherms (alpha-stat) nor hibernators (pH stat) and normally do not become hypothermic. The conclusions : there seems to be no neurologic disadvantage to alpha-stat management during continuous CPB at moderate hypothermia, and probably a slight advantage. However, the neurologic outcome differences between alpha-stat are not detectable until CPB durations are prolonged.

4. Systemic arterial Pressure
: CMRO2 are decreased during CPB (hypothermia, anesthesia) but the cerebral O2 delivery is reduced (hemodilution, hypothermia-induced CBF reduction). Therefore, the safe lower limit of MAP have been controversial. Conclusions : it may be particularly true that hypotension, low CO is clearly associated with adverse neurologic outcome. Increasing MAP increases CBF and may preserve viability of a region that would have died otherwise. Therefore, it makes perfect sense that hemodynamic instability post-CPB should contribute to neurologic morbidity.

5.
Barbiturates : Barbiturates have been considered to be "cerebral protective" agents. Many studies show controversies and lead to conclusion that under usual CPB conditions that cerebral embolization is small (use of membrane oxygenator, arterial filter) and/or hypothermic protection is already present, barbiturates are very unlikely to provide substantive brain protection. The most rational (but unproved) use of thiopental (or etomidate or propofol) might be those settings in w hich, under normothermia, a shower of emboli is anticipated (such as resumption of ejection after an open chamber procedure).

6. Pulsatile perfusion
: to date, no clinical evidence of superior neurologic outcome with pulsatile perfusion (animal stuides in the 1970s and 80s indicated that nonpulsatile flow unfavorably influenced cerebral perfusion). As practically achievable, it seems that pulsatile CPB has little effect on the brain or the processes resulting in brain injury during cardiac surgery

7. Hemodilution and postop. Anemia
: both human and animal studies indicate brain oxygenation is adequate with hematocrit (Hct) levels in the mid-20s during CPB at 27 °c. There was a study (Savagaeu et al., 1982) that report the neurologic impairment was associated with Hct levels < 30% in the first 12 hr after surgery. ASA guidelines for blood component therapy stated that "transfusion is rarely indicated when the Hb >10 g/dL and is almost always indicated when it is < 6 g/dL, especially when the anemia is acute."

Ref
Dinardo JA. Anesthesia for Cardiac Surgery 2nd Ed. Appleton & Lange 1998

 





   
16. AVR Surgery : Rx of hypertension back to top

AVR surgery is mostly performed for aortic valve stenosis (AS) more than aortic insufficiency. The pathophysiology of these 2 diseases are different. In AS, the global systolic LV function is well preserved until a very late and severe form of AS occurs. The gradient across the valve need to be maintain and acute decrease in systemic BP, particularly diastolic BP can be detrimental. Hemodynamic goals for AS and AR can be reviewed as follow.
   
 
AS
AR
Preload
inc
inc
Afterload
-/inc
-/dec
Contractility
-
-
Rate
avoid extremes
-/inc
Rhythm
maintain sinus
-
MvO2
potential problem
-
There are many causes of hypertension. During general anesthesia, an adequate anesthesia must be achieved before the antihypertensive treatment. Narcotic analgesics or potent inhalation anesthetic agent may be used. To reduce the BP in severe AS is very critical. The pressure gradient across the valve may drop and the diastolic pressure which determine the coronary perfusion may be too low against the increase in wall tension for subendocardial perfusion. The cardiac arrest that occur in severe AS has a very poor prognosis in term of resuscitation. The treatment plan can be formulated from the fact that BP = CO x SVR. In AS, to reduce the afterload is unfavorable. However, if necessary, the rapid onset and titratable drug e.g. Sodium Nitroprusside would be an ideal choice 2. To maintain the gradient across the valve, the only factor that can be altered to reduce the BP is to decrease the CO. In this case, the CO should be measured before and after treatment. The CO that is too low is also an unfavorable condition. The CO can be reduced by decrease the SV or heart rate or contractility. Decreased preload in AS is not suggested, the volume needed to be adequate to pass the stenotic valve. The heart rate can be reduced by b-blocker, the short acting and titratable drug like esmolol is an ideal choice. The contractility may be as well reduced by b-blocker or Ca channel blocker.

In AI, because the reduced afterload is preferable. The drugs that reduce SVR e.g. a adrenergic blocker, hydralazine, potent vasodilating anesthetic agent, ACEI, peripheral acting Ca Channel blocker, sodium nitroprusside, etc can be used.

Ref
1. Jackson JM. Valvular Heart Disease in Thomas SJ, Kramer JL : Manual of Cardiac Anesthesia 2nd ed. Churchill Livingstone 1993
2. Dinardo JA. Anesthesia for Vavle Replacement in Patients With Acquired Valvular Heart Disease. Dinardo JA : Anesthesia for Cardiac Surgery 2nd ed. Appleton & Lange 1998


 



   
17. Myocardial ischemia : Dx back to top

There are 3 terms regarding to actue coronary syndrome which are 3Is - Myocardial Ischemia, Myocardial Injury and Myocardial Infarction

Myocardial Ischemia occurs with a mismatch between the amount of blood flowing to a section of the heart and the amount of oxygen needed by that section of the haert. Usually desieased and narrow coronary arteries cause ischemia when they cannot carry enough blood to an area of the actively beating heart. Patients usually experience ischemia as chest pain and discomfort or angina. Ischemia can quickly resove by either reducing the oxygen needs of the heart (resting, slowing the rate with b-blockers) or increasing the blood flow (vasodilatation with nitroglycerin).

In awake patients, the presenting symptoms include chest pain, dysrhythmias, signs of ventricular failure. Some patients may be asymptomatic or the anesthetized patients, these symptoms can not detected. The EKG is still the gold standard for diagnosis of myocardial ischemia. The appropriate leads are leads II and V5 which are commonly used simultatneously. These combination has a high sensitivity but will not detect true posterior ischemia (esophageal ECG may be used). The changes in PCWP and PCWP waveform may be used intraoperatively but have poor sensitivity and specificity, so they canot be relied upon as the sole indicator of ischemia. The regional wall motion abnormalities (RWMA) from TEE are very helpful and numerous studies have shown it to be more sensitive than EKG changes and to be capable of detecting myocardial ischemia before EKG changes. But recent data show a lack of concordance between ischemia detected by EKG and that detected by TEE. There are both TEE-detected ischemia that not detected by TEE and EKG-detected ischemia which is not detected by TEE.
EKG changes
The typical EKG changes of ischemia are ST depression > 1 mm. The upsloping ST segment is often a nonspecific finding while the horizontal is more specific for ischemia and the down-sloping is most indicative of ischemia. The T-wave changes are less specific either T-wave inversion or tall, peaked, asymetrical T. However, Giant, hyperacute T are sometimes the only changes seen early in an AMI and these changes can be an indication for thrombolytic therapy. Some clinical conditions that can cause ST depression and T changes are digoxin, LVH, early repolarization, LBBB and pre-excitation.

Myocardial Injury
occurs if the period of ischemia is prolonged more than just a few minutes and Infarction refers to the actual death of injured myocardial cells. The hallmark of EKG changes in myocardial injury areST elevation (significant when ST segment measures > 1 mm above the PT baseline at a point 0.04 second (1 mm) past the J point. And the hallmark of EKG changes associated with infarction is the presence of abnormal Q waves. Q waves are considered abnormal if they are > 1 mm (0.04 sec) wide and the height greater than 25% of the height of the R wave in that lead. Q waves that are similar in width and height may indicate normal septal depolarization. Q waves indicate infarcted myocardial tissue. They can appear within hours after occlusion but usually not before 2 hours of onset of symptoms.

Ref
1. Dinardo JA. Anesthesia for Myocardial Revascularization p.83-91 in Anesthesia for Cardiac Surgery. 1998, 2nd editon. Appleton & Lange
2.American Heart Association. Chapter 9 p 9-23-9-24 The Acute Coronary Syndrome in Advanced Cardiac Life Support 1994-1997